Original articleSentinel lymph node involvement—a predictor for axillary node status with breast cancer—Has the time come?
References (8)
- et al.
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
Lancet
(1997) - et al.
Relation to tumour size, lymph node status and survival in 24,740 breast cancer cases
Cancer
(1989) Axillary node dissection: what role in managing breast cancer?
Contemp Oncol
(1944)- et al.
Axillary node dissection for early breast cancer: some is good but all is better
J Surg Oncol
(1992)
There are more references available in the full text version of this article.
Cited by (86)
Lymphatic mapping and sentinel lymphadenectomy for breast cancer
2018, The Breast: Comprehensive Management of Benign and Malignant DiseasesBreast
2009, Modern Surgical PathologyBreast
2009, Modern Surgical PathologyLymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
2009, The Breast: Comprehensive Management of Benign and Malignant DiseasesAxillary lymph node dose with tangential breast irradiation
2005, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :This more limited surgical procedure provides prognostic information regarding the status of the axillary lymph nodes and is associated with significantly less morbidity than standard axillary dissection, which can be avoided in patients with negative sentinel nodes (20). In patients with positive sentinel lymph nodes, it is well established that additional positive lymph nodes are present in 39–86% of patients. (13, 16, 21, 22). This would suggest the necessity for additional axillary treatment in the presence of positive sentinel nodes.
Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes
2004, Journal of the American College of Surgeons
Copyright © 1998 Published by Elsevier Ltd.